TotalMarketCap

Oculis

OCSNasdaq SwitzerlandHealth CareBiotechnology: Pharmaceutical Preparations

Market cap

$419.107 M

$6.81 -6.53%

Close of 6 Nov 2026

As of 6 Nov 2026, Oculis (OCS) has a market capitalization of $419.1M. Market cap measures the value of outstanding equity at market prices; company totals combine applicable share classes. Prices and market caps come from Nasdaq, with financial fundamentals from SEC filings. See sources and calculation details.

Revenue

—

Not reported

Earnings

—

Not reported

Shares outstanding

—

Latest filing cover page

P/E ratio

—

Cap ÷ net income

Other share classes

Oculis lists more than one class of stock. Company figures above cover all classes combined.

OCSAW

Biotechnology: Pharmaceutical Preparations, ranked by market cap

All 498 →
  1. #198Gyre TherapeuticsGYRE$446.6M
  2. #199ArvinasARVN$427.0M
  3. #200OculisOCS$419.1M
  4. #201Phathom PharmaceuticalsPHAT$413.0M
  5. #202CorMedixCRMD$407.3M

What if Oculis were worth as much as…

Open the what-if tool →

Gold $28.2T

$458,479.58

Per share 67,374× higher

Bitcoin $1.53T

$24,807.53

Per share 3,645× higher

Apple $5.02T

$81,440.81

Per share 11,968× higher

Or at a round number

$1.00B$2.00B$5.00B$10.0B

Where these numbers come from

Share counts and financials for Oculis are taken from its own SEC filings via EDGAR: public record, not an estimate. Market cap is shares outstanding multiplied by the latest close. Read the methodology.